Back to search

National and Kapodistrian University of Athens

Οι μηχανισμοί του τραυματισμού των ιστών και ο ρόλος της ενεργοποίησης του συμπληρώματος

Abstract

dc:description

Ischemia and Reperfusion (I/R) injury is a major complicating feature of many clinical conditions. I/R is responsible for much of the severity of myocardial infarction, cerebral ischemic events, intestinal ischemia and many aspects of vascular surgery, trauma and transplantation. Intestinal I/R is a devastating syndrome. The mortality rate of most gastrointestinal ischemia-related deaths is 70-90%. Injury and inflammation cause by I/R are prominent in the intestine due to the sensitivity of the mucosal surfaces and is frequently followed by remote organs such as liver and lung.During ischemia cells undergo immediate injury by hypoxia and undergo specific changes in enzymatic activities, mitocondrial function and cytoscheletal structure. They also reveal neoantigens on the surface membrane which are recognized by pathogenic natural antibodies leading to the classical complement activation. During the reperfusion phase the injury is significantly amplified by the return of blood flow. During this phase several important inflammatory mediators (complement, cytokines, adhesion molecules, eicosanoids) are generated and amplify the ischemic injury. There is also recruitment and activation of neutrophils in the site of injury triggered by the inflammatory mediators. Neutrophils contribute to the development of injury by producing reactive oxygen species (H2O2) although are not sufficient to cause tissue injury without the presence of complement.Previous studies have shown that Complement activation is also involved in the effector phases of intestinal I/R tissue injury. Inhibition of the complement components (C3, C5, C4) can either inhibit or attenuate intestinal I/R-induced tissue injury. During activation of the complement pathway inflammatory mediators are generated (anaphylatoxins C5a, C3a, and MAC) and cause cellular activation and injury. The three peptides released during the steps of complement activation, C3a, C4a, and C5a, are known as anaphylatoxins. Those peptides mediate multiple reactions in the acute inflammatory response, including smooth muscle conteraction , changes in vascular permeability, histamine release from mast cells, neutrophil chemotaxis, platelet activation and aggregation, as well as up-regulation of adhesion molecules that can also play key roles in neutrophil recruitment.The mechanism of complement activation during intestinal I/R injury remains unclear. There is also little information regarding the specific complement activation pathways (classical, alternative or lectin) involved in tissue injury. Many findings have implicated the classical pathway in this process. Although the alternative pathway may also be implicated. It has been proposed that natural IgM antibodies bind to neoantigens revealed by cells during the ischemic phase and activate complement through the classical pathway. Complement activation leads to the generation of the complement components C3, C5 and MAC, adhesion molecule expression increases and inflammatory mediators (LTB4 and others) are released.The complement system consists of serum and cellular proteins, including positive and negative regulators, linked in three biochemical cascades, the classical, the alternative and the lectin pathway. The system is regulated at multiple levels. This regulation facilitates recognition of self from foreign tissue and, therefore, allows the control over the potent tissue-damaging capabilities of complement activation. It has been recognized that some of the endogenous complement regulatory proteins might serve as potential therapeutic agents in blocking inappropriate activation of complement in human disease. Soluble and membrane-bound variants of complement regulators have been produced and shown to be effective in blocking complement activation in vitro as well as in animal models of complement-mediated pathologies.Our group has previously shown that neoantigens are expressed in the injured endothelium during ischemia and that autoantibodies (anti-phospholipid, anti-cardiolipin) recognize and bind those neoantigens and reconstitute mesenteric I/R induced organ injury (intestine and lung) in Cr-2-/- and Rag-1-/- mice following mesenteric I/R. In the present study we show that anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-/- mice and that the activation of complement plays a significant role in the injury. Anti-ribonucleoprotein antibodies were found to reconstitute mesenteric I/R induced injury in Rag-/- mice and to increase the inflammatory mediator production in the intestine. Also, were found to contribute in the enhancement of lung injury and in the production of inflammatory mediators in the lung. The observed injury in both organs increased with the rising of the anti-RNP titer and the anti-RNP antibodies are able to cause more injury in the lung compared to the intestine. We finally show that the organ injury mediated by the anti-ribonucleoprotein antibodies following mesenteric I/R is complement dependent by depleting complement activation using CVF.Furthermore, we show that the complement activation plays a significant role in the I/R induced injury of the remote organs in C57Bl/6 and B6.MRL/lpr mice subjected to hindlimb and mesenteric I/R using the membrane regulatory protein DAF (Decay Accelerating Factor). DAF was found to attenuate remote ischemia/reperfusion remote organ damage in C57Bl/6 mice subjected to hindlimb I/R, whereas it does not significantly affect the local injury (hindlimb or mesenteric). We show that the complement protein C3 is deposited in the hindlimb muscle following DAF treatment but there is no deposition of the membrane attack complex (MAC) on the surface of skeletal muscle. DAF significantly decreases injury in the remote organs (intestine and lung), with C3 deposition and without MAC deposition in the respective tissues. Similar results were found in the hindlimb I/R model as well as in the mesenteric I/R model in B6.MRL/lpr mice.The understanding of the mechanisms of tissue injury and the role of the regulators of complement activation will lead to the development of therapeutic interventions aiming to restore the function of the injured tissue and of remote tissues due to ischemia and reperfusion.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zacharia, Athina
  • Ζαχαριά, Αθηνά

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29331

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zacharia, Athina; Ζαχαριά, Αθηνά. Οι μηχανισμοί του τραυματισμού των ιστών και ο ρόλος της ενεργοποίησης του συμπληρώματος. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/29331